1) low molecular weight heparin
低分子肝素钙
1.
Clinical study on the curative effect of Shuxuetong injection and low molecular weight heparin on frequent transient ischemic attack;
疏血通联合低分子肝素钙治疗频发短暂性脑缺血发作的临床观察
2.
Objective To study the clinical effects of Xueshuantong with low molecular weight heparin for unstable angina(UA).
目的观察血栓通注射液联合低分子肝素钙治疗不稳定型心绞痛的临床疗效。
3.
Objective To investigate the influence of low molecular weight heparin on T cell subsets in the patients of Henoch-Schonlein purpura (HSP).
目的探讨低分子肝素钙对过敏性紫癜(HSP)血T细胞亚群的影响。
2) low molecular weight heparin calcium
低分子肝素钙
1.
Evaluate the efficacy of a combination of Honghua injection with low molecular weight heparin calcium on cerebral infarction;
红花注射液与低分子肝素钙联合治疗脑梗死疗效分析及观察
2.
The clinical observation of low molecular weight heparin calcium in treating the patients with acute cerebral infarction;
低分子肝素钙治疗急性脑梗死病人的临床观察
3.
Methods 135 cases with acute progressive cerebral infarction were randomly divided into 3 groups :united group(n=45)that treated with Edaravone by intravenous infusion of 30mg(bid×14d)and low molecular weight heparin calcium hyodermic injection of 0.
方法将135例急性进展性脑梗死患者随机分为3组:治疗组45例,采用依达拉奉30mg+NS100ml静滴,30min滴完,每日2次,连用14天,同时低分子肝素钙0。
3) low molecular heparin calcium
低分子肝素钙
1.
Therapentic effect of the small dosage urokinase and the low molecular heparin calcium for treament of 60 patients with cerebral infarction;
小剂量尿激酶与低分子肝素钙治疗急性脑梗死60例
2.
New progress on subcutaneous injection method of low molecular heparin calcium;
低分子肝素钙皮下注射方法新进展
3.
The clinical significance and nursing of low molecular heparin calcium in patients with unstable angina pectoris;
UAP患者应用低分子肝素钙的临床意义及护理
4) low-molecular-weight heparin calcium
低分子肝素钙
1.
Treatment effect observation of low-molecular-weight heparin calcium in preventing reinfarction after intravenous thrombolysis in acute cerebral infarction;
低分子肝素钙预防溶栓后再梗死疗效观察
2.
Clinical stady of low-molecular-weight heparin calcium in the treament of TIA;
低分子肝素钙治疗短暂性脑缺血发作的临床观察
3.
Clinical study of low-molecular-weight heparin calcium and aspirin therapy on acute cerebral infarction;
低分子肝素钙、阿司匹林联合治疗急性脑梗死的临床研究
5) LMWH
低分子肝素钙
1.
The Effects of LMWH and Clopidogrel on Plasma Hypercoagulation State in Type 2 Diabetic Patients;
低分子肝素钙联合氯吡格雷对2型糖尿病高凝状态的影响
2.
Objective To observe the clinical effect of low molecular weight heparin(LMWH)on acute coronary syndrome(ACS).
目的探讨低分子肝素钙治疗冠脉综合征(ACS)的临床疗效与安全性。
3.
In order to observe curative effect and security of Low Molecular Weight Heparins Calcium Injection(LMWH)used to prevent Deep Venous Thrombosis(DVT)forming after operation of fracture of lower limb.
为观察低分子肝素钙(Low Molecular Weight Heparins Calcium Injection LMWH)围术期应用预防下肢骨折术后深静脉血栓(Deep Venous Thrombosis DVT)的疗效和安全性。
6) Low molecular weight heparin calcium
低分子量肝素钙
1.
Study on the oral preparation of low molecular weight heparin calcium;
低分子量肝素钙口服制剂的研究
补充资料：肝素钙
分子式：暂无
分子量：暂无
CAS号：37270-89-6
性质：暂无
制备方法：暂无
用途：抗凝血药。
分子量：暂无
CAS号：37270-89-6
性质：暂无
制备方法：暂无
用途：抗凝血药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条